SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses
The Evolving Landscape of Coronavirus Immunity: Beyond ACE2 The story of SARS-CoV-2 has been one of constant evolution, from the virus itself to our understanding of how it infects and how our immune systems respond. While the ACE2 receptor initially took center stage as the primary entry point for the virus, research increasingly reveals a … Read more